Informacje
naukowe.

Dear Doctors,
The aim of this section is to support your daily work with pregnant women and to inspire you to talk to them about cord blood and cord tissue banking, as well as to keep you up to date on the current status of stem cell applications in medicine.

Thanks to our cooperation with medical specialists, Polski Bank Komórek Macierzystych is well informed of current medical news from around the world. We work with a number of scientific societies and transplant clinics. This section is dedicated to those interested in the current status of stem cells extracted from cord blood, as well as to doctors interested in the current status and progressions of cord blood applications in medical therapies.

Basic information on umbilical cord blood

The content of the material was reviewed by experts of the Polish Society of Paediatric Oncology and Haematology. The material was prepared for the XXXI Polish Association Congress.

Opinion of Polish Society of Pediatric Oncology and Hematology


The opinion on cord blood collection postulated by the Polish Gynaecological Society regarding the collection and storage of stem cells from cord blood

The Polish Gynaecological Society approves of cord blood banking in any form and grants women the freedom of decision-making.

Opinion of Polish Gynaecological Society


Publication specific to the first autologous cord blood transplant performed in Poland

The blood was stored at the Polish Stem Cell Bank and used for transplantation thanks to the collaboration of scientists from PAN and clinisists from the Children’s Health Centre.

Autologous Transplant from Cord Blood derived Stem Cells


Current statistics on the use and effectiveness of stem cells in therapies in the USA

The statistics can be viewed here:

https://bethematchclinical.org/resources-and-education/hct-presentation-slides/#/


Registry of research studies currently underway

Type in “cord blood stem cells” in the search engine

https://www.clinicaltrials.gov/


Transplanting Stem Cells Works for Scleroderma

Clinical trial showed how autologous blood stem cell transplants significantly improved survival in patients with high-risk scleroderma.

http://www.medpagetoday.com/MeetingCoverage/EULAR/33135

Name and surname
Invalid Input

E-mail
Invalid Input

Phone number
Invalid Input

Expected date of delivery
Invalid Input

Uprzejmie informujemy, że dane osobowe podane w formularzu będą przetwarzane przez Polski Bank Komórek Macierzystych S.A. („PBKM”) z siedzibą w Warszawie, Al. Jana Pawła II 29 w celu kontaktu telefonicznego w związku z udzieleniem informacji na temat usługi.

Zgody są wymagane

I hereby declare that I have read the PBKM data processing policy.

Zgody są wymagane

I hereby give my consent for marketing content to be transferred to the telephone number provided by me, including by means of automated calling systems under the Telecommunications Law Act of 16 July 2004 (Journal of Laws of 2017, item 1907, as amended) by Polski Bank Komórek Macierzystych.